FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Biomolecules / Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose...
Biomolecules2022; 12(8); 1039; doi: 10.3390/biom12081039

Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis.

Abstract: Astaxanthin is gaining recognition as a natural bioactive component. This study aimed to test whether astaxanthin could protect adipose-derived stromal stem cells (ASCs) from apoptosis, mitochondrial dysfunction and oxidative stress. was used to extract astaxanthin, whose biocompatibility was tested after 24, 48 and 72 h of incubation with the cells; no harmful impact was found. ASCs were treated with optimal concentrations of astaxanthin. Several parameters were examined: cell viability, apoptosis, reactive oxygen levels, mitochondrial dynamics and metabolism, superoxide dismutase activity, and astaxanthin's antioxidant capacity. A RT PCR analysis was performed after each test. The astaxanthin treatment significantly reduced apoptosis by modifying the normalized caspase activity of pro-apoptotic pathways (p21, p53, and Bax). Furthermore, by regulating the expression of related master factors SOD1, SOD2, PARKIN, PINK 1, and MFN 1, astaxanthin alleviated the oxidative stress and mitochondrial dynamics failure caused by EMS. Astaxanthin restored mitochondrial oxidative phosphorylation by stimulating markers associated with the OXPHOS machinery: COX4I1, COX4I2, UQCRC2, NDUFA9, and TFAM. Our results suggest that astaxanthin has the potential to open new possibilities for potential bio-drugs to control and suppress oxidative stress, thereby improving the overall metabolic status of equine ASCs suffering from metabolic syndrome.
Get Full Text
Publication Date: 2022-07-27 PubMed ID: 36008933PubMed Central: PMC9405637DOI: 10.3390/biom12081039Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Astaxanthin, a naturally available component, has demonstrated potential in maintaining cell health and mitigating oxidative stress in adipose-derived stromal stem cells (ASCs) taken from horses with equine metabolic syndrome in this research.

Objective and methodology

In this study, researchers examined whether astaxanthin could safeguard ASCs from apoptosis (programmed cell death), mitochondrial dysfunction, and oxidative stress. Using a special extraction method, astaxanthin was isolated and its biocompatibility tested over intervals of 24, 48, and 72 hours, with no harmful impacts found in cells. The researchers then used carefully measured concentrations of astaxanthin to treat the ASCs.

Parameters Examined

  • Cell viability, or how well the cells survived and functioned after being treated with astaxanthin.
  • Apoptosis, or how many cells underwent programmed death.
  • Reactive oxygen levels, which can indicate oxidative stress.
  • Mitochondrial dynamics, or changes in the mitochondrial structure and distribution, and metabolism.
  • Superoxide dismutase activity, an antioxidant defense in nearly all living cells exposed to oxygen.
  • The antioxidant capacity of astaxanthin, or how well it could neutralize the harmful effects of oxidative stress.

A RT PCR analysis was performed after each test to confirm the results.

Results

The outcomes have shown that astaxanthin treatment led to a significant reduction in apoptosis by modulating the normalized caspase activity linked to pro-apoptotic pathways, which drive programmed cell death. This was achieved by regulating the expression of master factors such as SOD1, SOD2, PARKIN, PINK 1, and MFN 1. These factors are connected to cell health and survival. Furthermore, astaxanthin alleviated the oxidative stress and failure in mitochondrial dynamics caused by equine metabolic syndrome. It restored mitochondrial oxidative phosphorylation, which is a vital cell process responsible for generating the majority of the cell’s energy, by stimulating markers related to this process like COX4I1, COX4I2, UQCRC2, NDUFA9, and TFAM.

Conclusion

The research suggests that astaxanthin may open new avenues for potential bio-drugs which can manage and suppress oxidative stress, yielding an improvement in the general metabolic state of equine ASCs suffering from metabolic syndrome.

Cite This Article

APA
Mularczyk M, Bourebaba N, Marycz K, Bourebaba L. (2022). Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis. Biomolecules, 12(8), 1039. https://doi.org/10.3390/biom12081039

Publication

Biomolecules
ISSN: 2218-273X
NlmUniqueID: 101596414
Country: Switzerland
Language: English
Volume: 12
Issue: 8
PII: 1039

Researcher Affiliations

Mularczyk, Malwina
  • Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375 Wrocław, Poland.
  • International Institute of Translational Medicine, Jesionowa 11, Malin, 55-114 Wisznia Mała, Poland.
Bourebaba, Nabila
  • Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375 Wrocław, Poland.
Marycz, Krzysztof
  • Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375 Wrocław, Poland.
  • International Institute of Translational Medicine, Jesionowa 11, Malin, 55-114 Wisznia Mała, Poland.
Bourebaba, Lynda
  • Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life Sciences, Norwida 27B, 50-375 Wrocław, Poland.

MeSH Terms

  • Animals
  • Carotenoids / metabolism
  • Horses
  • Metabolic Syndrome / drug therapy
  • Metabolic Syndrome / metabolism
  • Metabolic Syndrome / veterinary
  • Organelle Biogenesis
  • Oxidative Stress
  • Stromal Cells / metabolism
  • Xanthophylls

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 86 references
  1. Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic Syndrome.. 2023 Jan;.
    pubmed: 29083742
  2. Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review.. Nutr Metab (Lond) 2016;13:65.
    doi: 10.1186/s12986-016-0123-9pmc: PMC5050917pubmed: 27708685google scholar: lookup
  3. Gupta A, Gupta V. Metabolic syndrome: what are the risks for humans?. Biosci Trends 2010 Oct;4(5):204-12.
    pubmed: 21068471
  4. Grzesiak J, Marycz K, Czogala J, Wrzeszcz K, Nicpon J. Comparison of Behavior, Morphology and Morphometry of Equine and Canine Adipose Derived Mesenchymal Stem Cells in Culture.. Int. J. Morphol. 2011;29:1012–1017.
    doi: 10.4067/S0717-95022011000300059google scholar: lookup
  5. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome.. J Vet Intern Med 2019 Mar;33(2):335-349.
    doi: 10.1111/jvim.15423pmc: PMC6430910pubmed: 30724412google scholar: lookup
  6. Bourebaba L, Kornicka-Garbowska K, Al Naem M, Röcken M, Łyczko J, Marycz K. MSI-1436 improves EMS adipose derived progenitor stem cells in the course of adipogenic differentiation through modulation of ER stress, apoptosis, and oxidative stress.. Stem Cell Res Ther 2021 Feb 3;12(1):97.
    doi: 10.1186/s13287-020-02102-xpmc: PMC7860037pubmed: 33536069google scholar: lookup
  7. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.. J Endocrinol 2014 Feb;220(2):T1-T23.
    doi: 10.1530/JOE-13-0584pmc: PMC4087161pubmed: 24281010google scholar: lookup
  8. Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation.. Postepy Hig Med Dosw (Online) 2016 Dec 20;70(0):1245-1258.
    pubmed: 28026827
  9. Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance.. Physiol Rev 2018 Oct 1;98(4):2133-2223.
    doi: 10.1152/physrev.00063.2017pmc: PMC6170977pubmed: 30067154google scholar: lookup
  10. Beale EG. Insulin signaling and insulin resistance.. J Investig Med 2013 Jan;61(1):11-4.
    doi: 10.2310/JIM.0b013e3182746f95pmc: PMC3640267pubmed: 23111650google scholar: lookup
  11. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease.. Cardiovasc Diabetol 2018 Aug 31;17(1):122.
    doi: 10.1186/s12933-018-0762-4pmc: PMC6119242pubmed: 30170598google scholar: lookup
  12. Janus A, Szahidewicz-Krupska E, Mazur G, Doroszko A. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders.. Mediators Inflamm 2016;2016:3634948.
    doi: 10.1155/2016/3634948pmc: PMC4931075pubmed: 27413253google scholar: lookup
  13. Marycz K, Grzesiak J, Wrzeszcz K, Golonka P. Adipose Stem Cell Combined with Plasma-Based Implant Bone Tissue Differentiation in Vitro and in a Horse with a Phalanx Digitalis Distalis Fracture: A Case Report.. Veterinární Medicína 2012;57:610–617.
    doi: 10.17221/6469-VETMEDgoogle scholar: lookup
  14. Marycz K, Kornicka K, Grzesiak J, Śmieszek A, Szłapka J. Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation.. Oxid Med Cell Longev 2016;2016:3718468.
    doi: 10.1155/2016/3718468pmc: PMC5178365pubmed: 28053691google scholar: lookup
  15. Basinska K, Marycz K, Śieszek A, Nicpoń J. The production and distribution of IL-6 and TNF-a in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome.. J Vet Sci 2015;16(1):113-20.
    doi: 10.4142/jvs.2015.16.1.113pmc: PMC4367141pubmed: 25269712google scholar: lookup
  16. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese.. Biomed Pharmacother 2021 May;137:111315.
    doi: 10.1016/j.biopha.2021.111315pubmed: 33561645google scholar: lookup
  17. Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.. J Lipid Res 2007 Jun;48(6):1253-62.
    doi: 10.1194/jlr.R700005-JLR200pmc: PMC4303760pubmed: 17374880google scholar: lookup
  18. Luo L, Liu M. Adipose tissue in control of metabolism.. J Endocrinol 2016 Dec;231(3):R77-R99.
    doi: 10.1530/JOE-16-0211pmc: PMC7928204pubmed: 27935822google scholar: lookup
  19. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease.. Nat Rev Immunol 2011 Feb;11(2):85-97.
    doi: 10.1038/nri2921pmc: PMC3518031pubmed: 21252989google scholar: lookup
  20. Reynolds A, Keen JA, Fordham T, Morgan RA. Adipose tissue dysfunction in obese horses with equine metabolic syndrome.. Equine Vet J 2019 Nov;51(6):760-766.
    doi: 10.1111/evj.13097pmc: PMC6850304pubmed: 30866087google scholar: lookup
  21. Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus.. Compr Physiol 2018 Dec 13;9(1):1-58.
    doi: 10.1002/cphy.c170040pmc: PMC6557583pubmed: 30549014google scholar: lookup
  22. Marycz K, Basinska K, Toker N.Y., Śmieszek A, Nicpoń J. Atlarda Metabolik Sendrom (EMS) Sancısında, Adipoz Dokuda ve Periferal Kanda IL-6 ve TNF-α Nın Aktivitesi.. Kafkas Univ. Vet. Fak. Derg. 2014;20:493–499.
    doi: 10.9775/kvfd.2013.10334google scholar: lookup
  23. Langin D. Control of fatty acid and glycerol release in adipose tissue lipolysis.. C R Biol 2006 Aug;329(8):598-607; discussion 653-5.
    doi: 10.1016/j.crvi.2005.10.008pubmed: 16860278google scholar: lookup
  24. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance.. Physiol Rev 2007 Apr;87(2):507-20.
    doi: 10.1152/physrev.00024.2006pmc: PMC2995548pubmed: 17429039google scholar: lookup
  25. Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, Beguinot F. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes.. Front Physiol 2019;10:1607.
    doi: 10.3389/fphys.2019.01607pmc: PMC7000657pubmed: 32063863google scholar: lookup
  26. Kornicka K, Szłapka-Kosarzewska J, Śmieszek A, Marycz K. 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy.. J Cell Mol Med 2019 Jan;23(1):237-259.
    doi: 10.1111/jcmm.13914pmc: PMC6307768pubmed: 30370650google scholar: lookup
  27. Shin S, El-Sabbagh AS, Lukas BE, Tanneberger SJ, Jiang Y. Adipose stem cells in obesity: challenges and opportunities.. Biosci Rep 2020 Jun 26;40(6).
    doi: 10.1042/BSR20194076pmc: PMC7284323pubmed: 32452515google scholar: lookup
  28. Schosserer M, Grillari J, Wolfrum C, Scheideler M. Age-Induced Changes in White, Brite, and Brown Adipose Depots: A Mini-Review.. Gerontology 2018;64(3):229-236.
    doi: 10.1159/000485183pubmed: 29212073google scholar: lookup
  29. Masschelin PM, Cox AR, Chernis N, Hartig SM. The Impact of Oxidative Stress on Adipose Tissue Energy Balance.. Front Physiol 2019;10:1638.
    doi: 10.3389/fphys.2019.01638pmc: PMC6987041pubmed: 32038305google scholar: lookup
  30. Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling (Review).. Int J Mol Med 2019 Jul;44(1):3-15.
    doi: 10.3892/ijmm.2019.4188pmc: PMC6559295pubmed: 31115493google scholar: lookup
  31. Alfadda AA, Sallam RM. Reactive oxygen species in health and disease.. J Biomed Biotechnol 2012;2012:936486.
    doi: 10.1155/2012/936486pmc: PMC3424049pubmed: 22927725google scholar: lookup
  32. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury.. Free Radic Biol Med 2000 May 15;28(10):1456-62.
    doi: 10.1016/S0891-5849(00)00252-5pubmed: 10927169google scholar: lookup
  33. Castro JP, Grune T, Speckmann B. The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction.. Biol Chem 2016 Aug 1;397(8):709-24.
    doi: 10.1515/hsz-2015-0305pubmed: 27031218google scholar: lookup
  34. Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative Stress: Harms and Benefits for Human Health.. Oxid Med Cell Longev 2017;2017:8416763.
    doi: 10.1155/2017/8416763pmc: PMC5551541pubmed: 28819546google scholar: lookup
  35. Preiser JC. Oxidative stress.. JPEN J Parenter Enteral Nutr 2012 Mar;36(2):147-54.
    doi: 10.1177/0148607111434963pubmed: 22301329google scholar: lookup
  36. Pérez-Torres I, Castrejón-Téllez V, Soto ME, Rubio-Ruiz ME, Manzano-Pech L, Guarner-Lans V. Oxidative Stress, Plant Natural Antioxidants, and Obesity.. Int J Mol Sci 2021 Feb 11;22(4).
    doi: 10.3390/ijms22041786pmc: PMC7916866pubmed: 33670130google scholar: lookup
  37. Mularczyk M, Michalak I, Marycz K. Astaxanthin and other Nutrients from Haematococcus pluvialis-Multifunctional Applications.. Mar Drugs 2020 Sep 7;18(9).
    doi: 10.3390/md18090459pmc: PMC7551667pubmed: 32906619google scholar: lookup
  38. Grimmig B, Kim SH, Nash K, Bickford PC, Douglas Shytle R. Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.. Geroscience 2017 Feb;39(1):19-32.
    doi: 10.1007/s11357-017-9958-xpmc: PMC5352583pubmed: 28299644google scholar: lookup
  39. Gowd V, Xiao J, Wang M, Chen F, Cheng KW. Multi-Mechanistic Antidiabetic Potential of Astaxanthin: An Update on Preclinical and Clinical Evidence.. Mol Nutr Food Res 2021 Dec;65(24):e2100252.
    doi: 10.1002/mnfr.202100252pubmed: 34636497google scholar: lookup
  40. Chang MX, Xiong F. Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions.. Molecules 2020 Nov 16;25(22).
    doi: 10.3390/molecules25225342pmc: PMC7696511pubmed: 33207669google scholar: lookup
  41. Giannaccare G, Pellegrini M, Senni C, Bernabei F, Scorcia V, Cicero AFG. Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights.. Mar Drugs 2020 May 1;18(5).
    doi: 10.3390/md18050239pmc: PMC7281326pubmed: 32370045google scholar: lookup
  42. Masoudi A, Dargahi L, Abbaszadeh F, Pourgholami MH, Asgari A, Manoochehri M, Jorjani M. Neuroprotective effects of astaxanthin in a rat model of spinal cord injury.. Behav Brain Res 2017 Jun 30;329:104-110.
    doi: 10.1016/j.bbr.2017.04.026pubmed: 28442361google scholar: lookup
  43. Jafari Z, Bigham A, Sadeghi S, Dehdashti SM, Rabiee N, Abedivash A, Bagherzadeh M, Nasseri B, Karimi-Maleh H, Sharifi E, Varma RS, Makvandi P. Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications.. J Med Chem 2022 Jan 13;65(1):2-36.
    doi: 10.1021/acs.jmedchem.1c01144pmc: PMC8762669pubmed: 34919379google scholar: lookup
  44. Landon R, Gueguen V, Petite H, Letourneur D, Pavon-Djavid G, Anagnostou F. Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications.. Mar Drugs 2020 Jul 9;18(7).
    doi: 10.3390/md18070357pmc: PMC7401277pubmed: 32660119google scholar: lookup
  45. Kim YJ, Kim YA, Yokozawa T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin.. J Agric Food Chem 2009 Oct 14;57(19):8793-7.
    doi: 10.1021/jf9019745pubmed: 19731916google scholar: lookup
  46. Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, C뫝a F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Sanz Y, Schlatter JR, van Loveren H, Ackerl R, Gelbmann W, Steinkellner H, Knutsen HK. Safety of astaxanthin for its use as a novel food in food supplements.. EFSA J 2020 Feb;18(2):e05993.
    doi: 10.2903/j.efsa.2020.5993pmc: PMC7448075pubmed: 32874213google scholar: lookup
  47. Earnest CP, Lupo M, White KM, Church TS. Effect of astaxanthin on cycling time trial performance.. Int J Sports Med 2011 Nov;32(11):882-8.
    doi: 10.1055/s-0031-1280779pubmed: 21984399google scholar: lookup
  48. Tominaga K, Hongo N, Fujishita M, Takahashi Y, Adachi Y. Protective effects of astaxanthin on skin deterioration.. J Clin Biochem Nutr 2017 Jul;61(1):33-39.
    doi: 10.3164/jcbn.17-35pmc: PMC5525019pubmed: 28751807google scholar: lookup
  49. Tian L, Wen Y, Li S, Zhang P, Wang Y, Wang J, Cao K, Du L, Wang N, Jie Y. Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.. Front Nutr 2021;8:796951.
    doi: 10.3389/fnut.2021.796951pmc: PMC8792747pubmed: 35096941google scholar: lookup
  50. Shatoor AS, Al Humayed S. Astaxanthin Ameliorates high-fat diet-induced cardiac damage and fibrosis by upregulating and activating SIRT1.. Saudi J Biol Sci 2021 Dec;28(12):7012-7021.
    doi: 10.1016/j.sjbs.2021.07.079pmc: PMC8626242pubmed: 34867002google scholar: lookup
  51. Murai T, Kawasumi K, Tominaga K, Okada Y, Kobayashi M, Arai T. Effects of astaxanthin supplementation in healthy and obese dogs.. Vet Med (Auckl) 2019;10:29-35.
    doi: 10.2147/VMRR.S186202pmc: PMC6385744pubmed: 30859086google scholar: lookup
  52. Marycz K, Toker N.Y., Grzesiak J, Wrzeszcz K, Golonka P. The Therapeutic Effect of Autogenic Adipose Derived Stem Cells Combined with Autogenic Platelet Rich Plasma in Tendons Disorders Hi Horses in Vitro and in Vivo Research.. J. Anim. Vet. Adv. 2012;11:4324–4331.
  53. Bourebaba L, Bedjou F, Röcken M, Marycz K. Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation.. Stem Cell Res Ther 2019 Jun 18;10(1):178.
    doi: 10.1186/s13287-019-1292-zpmc: PMC6582509pubmed: 31215461google scholar: lookup
  54. Kohandel Z, Farkhondeh T, Aschner M, Pourbagher-Shahri AM, Samarghandian S. Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases.. Biomed Pharmacother 2022 Jan;145:112179.
    doi: 10.1016/j.biopha.2021.112179pubmed: 34736076google scholar: lookup
  55. Donoso A, González-Durán J, Muñoz AA, González PA, Agurto-Muñoz C. "Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials".. Pharmacol Res 2021 Apr;166:105479.
    doi: 10.1016/j.phrs.2021.105479pubmed: 33549728google scholar: lookup
  56. Nishida Y, Nawaz A, Hecht K, Tobe K. Astaxanthin as a Novel Mitochondrial Regulator: A New Aspect of Carotenoids, beyond Antioxidants.. Nutrients 2021 Dec 27;14(1).
    doi: 10.3390/nᐁ0107pmc: PMC8746862pubmed: 35010981google scholar: lookup
  57. Baburina Y, Krestinin R, Odinokova I, Sotnikova L, Kruglov A, Krestinina O. Astaxanthin Inhibits Mitochondrial Permeability Transition Pore Opening in Rat Heart Mitochondria.. Antioxidants (Basel) 2019 Nov 21;8(12).
    doi: 10.3390/antiox8120576pmc: PMC6943429pubmed: 31766490google scholar: lookup
  58. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance.. Mol Med 2008 Nov-Dec;14(11-12):741-51.
    doi: 10.2119/2008-00058.Rabepmc: PMC2582855pubmed: 19009016google scholar: lookup
  59. Weiss C, Kornicka-Grabowska K, Mularczyk M, Siwinska N, Marycz K. Extracellular Microvesicles (MV's) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells.. Stem Cell Rev Rep 2020 Dec;16(6):1343-1355.
    doi: 10.1007/s12015-020-10035-4pmc: PMC7667134pubmed: 32880856google scholar: lookup
  60. Cui G, Li L, Xu W, Wang M, Jiao D, Yao B, Xu K, Chen Y, Yang S, Long M, Li P, Guo Y. Astaxanthin Protects Ochratoxin A-Induced Oxidative Stress and Apoptosis in the Heart via the Nrf2 Pathway.. Oxid Med Cell Longev 2020;2020:7639109.
    doi: 10.1155/2020/7639109pmc: PMC7073479pubmed: 32190177google scholar: lookup
  61. Guo SX, Zhou HL, Huang CL, You CG, Fang Q, Wu P, Wang XG, Han CM. Astaxanthin attenuates early acute kidney injury following severe burns in rats by ameliorating oxidative stress and mitochondrial-related apoptosis.. Mar Drugs 2015 Apr 13;13(4):2105-23.
    doi: 10.3390/md13042105pmc: PMC4413202pubmed: 25871290google scholar: lookup
  62. Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: An intimate relationship.. Biochim Biophys Acta Mol Cell Res 2019 Dec;1866(12):118535.
    doi: 10.1016/j.bbamcr.2019.118535pubmed: 31446062google scholar: lookup
  63. Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies.. Life Sci 2016 Mar 1;148:183-93.
    doi: 10.1016/j.lfs.2016.02.002pubmed: 26851532google scholar: lookup
  64. Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, Ono H, Fujishiro M, Kushiyama A, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Gotoh Y, Komuro I, Fujita T. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase.. Diabetologia 2004 May;47(5):794-805.
    doi: 10.1007/s00125-004-1391-xpubmed: 15127200google scholar: lookup
  65. Yubero-Serrano EM, Delgado-Lista J, Peña-Orihuela P, Perez-Martinez P, Fuentes F, Marin C, Tunez I, Tinahones FJ, Perez-Jimenez F, Roche HM, Lopez-Miranda J. Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.. Exp Mol Med 2013 Jun 21;45(6):e28.
    doi: 10.1038/emm.2013.53pmc: PMC3701288pubmed: 23788131google scholar: lookup
  66. Marycz K, Weiss C, Śmieszek A, Kornicka K. Evaluation of Oxidative Stress and Mitophagy during Adipogenic Differentiation of Adipose-Derived Stem Cells Isolated from Equine Metabolic Syndrome (EMS) Horses.. Stem Cells Int 2018;2018:5340756.
    doi: 10.1155/2018/5340756pmc: PMC6011082pubmed: 29977307google scholar: lookup
  67. Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive Oxygen Species in Metabolic and Inflammatory Signaling.. Circ Res 2018 Mar 16;122(6):877-902.
    doi: 10.1161/CIRCRESAHA.117.311401pmc: PMC5926825pubmed: 29700084google scholar: lookup
  68. Kohandel Z, Farkhondeh T, Aschner M, Samarghandian S. Nrf2 a molecular therapeutic target for Astaxanthin.. Biomed Pharmacother 2021 May;137:111374.
    doi: 10.1016/j.biopha.2021.111374pubmed: 33761600google scholar: lookup
  69. Pereira CPM, Souza ACR, Vasconcelos AR, Prado PS, Name JJ. Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review).. Int J Mol Med 2021 Jan;47(1):37-48.
    doi: 10.3892/ijmm.2020.4783pmc: PMC7723678pubmed: 33155666google scholar: lookup
  70. Barros MP, Pinto E, Colepicolo P, Pedersén M. Astaxanthin and peridinin inhibit oxidative damage in Fe(2+)-loaded liposomes: scavenging oxyradicals or changing membrane permeability?. Biochem Biophys Res Commun 2001 Oct 19;288(1):225-32.
    doi: 10.1006/bbrc.2001.5765pubmed: 11594777google scholar: lookup
  71. Xue Y, Sun C, Hao Q, Cheng J. Astaxanthin ameliorates cardiomyocyte apoptosis after coronary microembolization by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats.. Naunyn Schmiedebergs Arch Pharmacol 2019 Mar;392(3):341-348.
    doi: 10.1007/s00210-018-1595-0pubmed: 30506291google scholar: lookup
  72. Marycz K, Kornicka K, Irwin-Houston JM, Weiss C. Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.. J Cell Mol Med 2018 Oct;22(10):4771-4793.
    doi: 10.1111/jcmm.13731pmc: PMC6156237pubmed: 29999247google scholar: lookup
  73. Kim SH, Kim H. Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review.. Nutrients 2018 Aug 21;10(9).
    doi: 10.3390/nဉ1137pmc: PMC6165470pubmed: 30134611google scholar: lookup
  74. Nishida Y, Nawaz A, Kado T, Takikawa A, Igarashi Y, Onogi Y, Wada T, Sasaoka T, Yamamoto S, Sasahara M, Imura J, Tokuyama K, Usui I, Nakagawa T, Fujisaka S, Kunimasa Y, Tobe K. Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway.. J Cachexia Sarcopenia Muscle 2020 Feb;11(1):241-258.
    doi: 10.1002/jcsm.12530pmc: PMC7015247pubmed: 32003547google scholar: lookup
  75. Krestinina O, Baburina Y, Krestinin R, Odinokova I, Fadeeva I, Sotnikova L. Astaxanthin Prevents Mitochondrial Impairment Induced by Isoproterenol in Isolated Rat Heart Mitochondria.. Antioxidants (Basel) 2020 Mar 23;9(3).
    doi: 10.3390/antiox9030262pmc: PMC7139515pubmed: 32210012google scholar: lookup
  76. Krestinina O, Baburina Y, Krestinin R. Mitochondrion as a Target of Astaxanthin Therapy in Heart Failure.. Int J Mol Sci 2021 Jul 26;22(15).
    doi: 10.3390/ijms22157964pmc: PMC8347622pubmed: 34360729google scholar: lookup
  77. Chen Y, Tie S, Zhang X, Zhang L, Tan M. Preparation and characterization of glycosylated protein nanoparticles for astaxanthin mitochondria targeting delivery.. Food Funct 2021 Sep 7;12(17):7718-7727.
    doi: 10.1039/D1FO01751Apubmed: 34286807google scholar: lookup
  78. Yu T, Dohl J, Chen Y, Gasier HG, Deuster PA. Astaxanthin but not quercetin preserves mitochondrial integrity and function, ameliorates oxidative stress, and reduces heat-induced skeletal muscle injury.. J Cell Physiol 2019 Aug;234(8):13292-13302.
    doi: 10.1002/jcp.28006pubmed: 30609021google scholar: lookup
  79. Jiang W, Zhao H, Zhang L, Wu B, Zha Z. Maintenance of mitochondrial function by astaxanthin protects against bisphenol A-induced kidney toxicity in rats.. Biomed Pharmacother 2020 Jan;121:109629.
    doi: 10.1016/j.biopha.2019.109629pubmed: 31733573google scholar: lookup
  80. Bergman O, Ben-Shachar D. Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.. Can J Psychiatry 2016 Aug;61(8):457-69.
    doi: 10.1177/0706743716648290pmc: PMC4959648pubmed: 27412728google scholar: lookup
  81. Chaban Y, Boekema EJ, Dudkina NV. Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation.. Biochim Biophys Acta 2014 Apr;1837(4):418-26.
    doi: 10.1016/j.bbabio.2013.10.004pubmed: 24183696google scholar: lookup
  82. Bourebaba N, Kornicka-Garbowska K, Marycz K, Bourebaba L, Kowalczuk A. Laurus nobilis ethanolic extract attenuates hyperglycemia and hyperinsulinemia-induced insulin resistance in HepG2 cell line through the reduction of oxidative stress and improvement of mitochondrial biogenesis - Possible implication in pharmacotherapy.. Mitochondrion 2021 Jul;59:190-213.
    doi: 10.1016/j.mito.2021.06.003pubmed: 34091077google scholar: lookup
  83. Sato F, Omura T, Ishimaru M, Endo Y, Murase H, Yamashita E. Effects of Daily Astaxanthin and L-Carnitine Supplementation for Exercise-Induced Muscle Damage in Training Thoroughbred Horses.. J. Equine Vet. Sci. 2015;35:836–842.
    doi: 10.1016/j.jevs.2015.08.003google scholar: lookup
  84. Nawrocka D, Kornicka K, Śmieszek A, Marycz K. Spirulina platensis Improves Mitochondrial Function Impaired by Elevated Oxidative Stress in Adipose-Derived Mesenchymal Stromal Cells (ASCs) and Intestinal Epithelial Cells (IECs), and Enhances Insulin Sensitivity in Equine Metabolic Syndrome (EMS) Horses.. Mar Drugs 2017 Aug 3;15(8).
    doi: 10.3390/md15080237pmc: PMC5577592pubmed: 28771165google scholar: lookup
  85. Hussein G, Nakagawa T, Goto H, Shimada Y, Matsumoto K, Sankawa U, Watanabe H. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp.. Life Sci 2007 Jan 16;80(6):522-9.
    doi: 10.1016/j.lfs.2006.09.041pubmed: 17074368google scholar: lookup
  86. Zhuge F, Ni Y, Wan C, Liu F, Fu Z. Anti-diabetic effects of astaxanthin on an STZ-induced diabetic model in rats.. Endocr J 2021 Apr 28;68(4):451-459.
    doi: 10.1507/endocrj.EJ20-0699pubmed: 33268598google scholar: lookup

Citations

This article has been cited 13 times.
  1. Bourebaba N, Sikora M, Qasem B, Bourebaba L, Marycz K. Sex hormone-binding globulin (SHBG) mitigates ER stress and improves viability and insulin sensitivity in adipose-derived mesenchymal stem cells (ASC) of equine metabolic syndrome (EMS)-affected horses. Cell Commun Signal 2023 Sep 11;21(1):230.
    doi: 10.1186/s12964-023-01254-6pubmed: 37697311google scholar: lookup
  2. Pielok A, Kępska M, Steczkiewicz Z, Grobosz S, Bourebaba L, Marycz K. Equine Hoof Progenitor Cells Display Increased Mitochondrial Metabolism and Adaptive Potential to a Highly Pro-Inflammatory Microenvironment. Int J Mol Sci 2023 Jul 14;24(14).
    doi: 10.3390/ijms241411446pubmed: 37511204google scholar: lookup
  3. Kowalczuk A, Marycz K, Kornicka J, Groborz S, Meissner J, Mularczyk M. Tetrahydrocannabivarin (THCV) Protects Adipose-Derived Mesenchymal Stem Cells (ASC) against Endoplasmic Reticulum Stress Development and Reduces Inflammation during Adipogenesis. Int J Mol Sci 2023 Apr 12;24(8).
    doi: 10.3390/ijms24087120pubmed: 37108282google scholar: lookup
  4. Zhao Y, Wang Z, Liu S, Xie S, Xie Y, Li R, Oda H. Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension. Biomolecules 2023 Mar 8;13(3).
    doi: 10.3390/biom13030496pubmed: 36979431google scholar: lookup
  5. Marycz K, Bourebaba N, Serwotka-Suszczak A, Mularczyk M, Galuppo L, Bourebaba L. In Vitro Generated Equine Hepatic-Like Progenitor Cells as a Novel Potent Cell Pool for Equine Metabolic Syndrome (EMS) Treatment. Stem Cell Rev Rep 2023 May;19(4):1124-1134.
    doi: 10.1007/s12015-023-10507-3pubmed: 36658383google scholar: lookup
  6. Torres-Haro A, Mateos-Díaz JC, Kirchmayr MR, Verdín J, Arellano-Plaza M. Astaxanthin biosynthesis stimulation in wild type Xanthophyllomyces dendrorhous allows transcriptional reprogramming of genetic responses involved in oxidative stress and mitochondrial defense. World J Microbiol Biotechnol 2026 Feb 17;42(3):90.
    doi: 10.1007/s11274-026-04814-3pubmed: 41701386google scholar: lookup
  7. Bourebaba N, Domagała J, Bourebaba L. Revitalizing equine metabolism: how SHBG improves mitochondrial function and reduces inflammation. BMC Vet Res 2025 Oct 21;21(1):620.
    doi: 10.1186/s12917-025-05033-ypubmed: 41121214google scholar: lookup
  8. Li C, Yan Y, Wang K, Jiang T. Astaxanthin alleviates oxidative stress and skeletal muscle damage by promoting mitochondrial biogenesis. Front Vet Sci 2025;12:1577408.
    doi: 10.3389/fvets.2025.1577408pubmed: 40963587google scholar: lookup
  9. Giercuszkiewicz-Hecold B, Pajuelo D, Steczkiewicz Z, Cywinska A, Marycz K. Astaxanthin supplementation in Arabian racing horses mitigates oxidative stress and inflammation in peripheral blood mononuclear cells through enhanced mitophagy. Sci Rep 2025 Apr 26;15(1):14633.
    doi: 10.1038/s41598-025-93661-7pubmed: 40287452google scholar: lookup
  10. Kawaida MY, Kwon OS, Ahn A, Reiter AS, Tillquist NM, Noh SG, Lee JW, Moore TE, Reed SA. Effects of an astaxanthin-containing supplement on oxidative status in skeletal muscle and circulation during deconditioning and reconditioning periods in polo ponies. Physiol Rep 2025 Apr;13(8):e70346.
    doi: 10.14814/phy2.70346pubmed: 40285451google scholar: lookup
  11. Giercuszkiewicz-Hecold B, Kulka M, Czopowicz M, Wilczak J, Szarska E, Strzelec K, Grzeczka A, Graczyk S, Hryniszyn A, Mularczyk M, Marycz K, Cywińska A. The effect of long term astaxanthin supplementation on the antioxidant status of racing Arabian horses - preliminary study. Sci Rep 2024 Nov 14;14(1):27991.
    doi: 10.1038/s41598-024-77732-9pubmed: 39543175google scholar: lookup
  12. Liao Z, He X, Chen A, Zhong J, Lin S, Guo Y, Cui X, Chen B, Zhao W, Niu J. Astaxanthin attenuates glucose-induced liver injury in largemouth bass: role of p38MAPK and PI3K/Akt signaling pathways. Cell Biosci 2024 Sep 19;14(1):122.
    doi: 10.1186/s13578-024-01304-7pubmed: 39300527google scholar: lookup
  13. Giercuszkiewicz-Hecold B, Kulka M, Czopowicz M, Szarska E, Strzelec K, Grzeczka A, Graczyk S, Wiśniewska M, Jędrzejkowska Z, Rumińska A, Marycz K, Cywińska A. Astaxanthin Supplementation Does Not Alter Training-Related Changes in Inflammatory Cytokine Profile in Arabian Racing Horses. Antioxidants (Basel) 2024 Jul 26;13(8).
    doi: 10.3390/antiox13080905pubmed: 39199150google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.